Salmonellosis cost-effectiveness of therapy

Jump to navigation Jump to search

Salmonellosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Salmonellosis from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Treatment

Medical Therapy

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Salmonellosis cost-effectiveness of therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Salmonellosis cost-effectiveness of therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Salmonellosis cost-effectiveness of therapy

CDC on Salmonellosis cost-effectiveness of therapy

Salmonellosis cost-effectiveness of therapy in the news

Blogs on Salmonellosis cost-effectiveness of therapy

Directions to Hospitals Treating Salmonellosis

Risk calculators and risk factors for Salmonellosis cost-effectiveness of therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2] Jolanta Marszalek, M.D. [3]

Overview[edit]

Although most cases of salmonellosis are not complicated, supportive and symptomatic treatment are mandatory in order to avoid worsening of the condition. Additionally, salmonellosis may incapacitate the affected persons for several days, jeopardizing their ability to work. Therefore, the treatment and prevention of salmonellosis may be considered cost-effective.

References[edit]


Template:WikiDoc Sources